Literature DB >> 25697161

Secondary surgery after vaginal prolapse repair with mesh is more common for stress incontinence and voiding dysfunction than for mesh problems or prolapse recurrence.

Jamie M Bartley1, Larry T Sirls, Kim A Killinger, Judith A Boura.   

Abstract

OBJECTIVES: To explore the need for secondary surgical procedures after transvaginal prolapse repair with mesh.
METHODS: Women that had prolapse repair (Prolift(®) or Elevate(®)) were reviewed for reoperation and clinical/demographic data such as prior prolapse repair, prolapse grade, operative details, length of stay (LOS) and time to reoperation. Pearson's Chi-square, Fisher's exact tests and Wilcoxon rank tests were used.
RESULTS: 77/335 women (23%) had 100 additional procedures. Median (range) time to reoperation was 51 (5-1168) days: four (1%) had primary prolapse surgery at a different site, three (1%) repeat prolapse repair from the same site, 23 (7%) surgery for complications and 50 (15%) had stress urinary incontinence (SUI)/sling-related procedures. When no reoperation versus reoperation groups were compared, mean LOS (1.8 vs. 2.0 days; p = 0.044) and follow-up (228 vs. 354 days; p = 0.002) were longer in the reoperations group; postoperative hemoglobin was lower (10.8 vs. 10.4; p = 0.031). Patients with a prolapse reoperation were 10 years younger (67 vs. 57 years; p = 0.027) than patients that either had a reoperation for other reasons or had no reoperations. Patients with concomitant sling and persistent SUI requiring repeat SUI surgery were older (mean 72 vs. 66 years; p = 0.038), had prior prolapse repair (53 vs. 27%; p = 0.017) and had anterior compartment mesh (84 vs. 56%; p = 0.037); median operative times (78 vs. 104 min; p = 0.008) and mean LOS were shorter (median 1.6 vs. 1.9 days; p = 0.045). For patients without concomitant sling, no demographic or perioperative differences were found between those that did (n = 10) and did not (n = 86) develop de novo SUI that required reoperation.
CONCLUSIONS: Most reoperations were for sling management and SUI; few were for mesh complications or prolapse recurrence.

Entities:  

Mesh:

Year:  2015        PMID: 25697161     DOI: 10.1007/s11255-015-0930-3

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  19 in total

1.  An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for reporting outcomes of surgical procedures for pelvic organ prolapse.

Authors:  Philip Toozs-Hobson; Robert Freeman; Matthew Barber; Christopher Maher; Bernard Haylen; Stavros Athanasiou; Steven Swift; Kristene Whitmore; Gamal Ghoniem; Dirk de Ridder
Journal:  Int Urogynecol J       Date:  2012-05       Impact factor: 2.894

2.  Perioperative complications and reoperations after incontinence and prolapse surgeries using prosthetic implants.

Authors:  John N Nguyen; Sharon M Jakus-Waldman; Andrew J Walter; Terry White; Shawn A Menefee
Journal:  Obstet Gynecol       Date:  2012-03       Impact factor: 7.661

3.  Primary surgical repair of anterior vaginal prolapse: a randomised trial comparing anatomical and functional outcome between anterior colporrhaphy and trocar-guided transobturator anterior mesh.

Authors:  A Vollebregt; K Fischer; D Gietelink; C H van der Vaart
Journal:  BJOG       Date:  2011-08-22       Impact factor: 6.531

4.  Surgical intervention after transvaginal Prolift mesh repair: retrospective single-center study including 524 patients with 3 years' median follow-up.

Authors:  Laurent de Landsheere; Sharif Ismail; Jean-Philippe Lucot; Valérie Deken; Jean-Michel Foidart; Michel Cosson
Journal:  Am J Obstet Gynecol       Date:  2011-07-30       Impact factor: 8.661

5.  Baseline urodynamic predictors of treatment failure 1 year after mid urethral sling surgery.

Authors:  Charles W Nager; Larry Sirls; Heather J Litman; Holly Richter; Ingrid Nygaard; Toby Chai; Stephen Kraus; Halina Zyczynski; Kim Kenton; Liyuan Huang; John Kusek; Gary Lemack
Journal:  J Urol       Date:  2011-06-16       Impact factor: 7.450

6.  Exploring predictors of mesh exposure after vaginal prolapse repair.

Authors:  Larry T Sirls; Gregory P McLennan; Kim A Killinger; Judith A Boura; Melissa Fischer; Pradeep Nagaraju; Kenneth Peters
Journal:  Female Pelvic Med Reconstr Surg       Date:  2013 Jul-Aug       Impact factor: 2.091

7.  The age distribution, rates, and types of surgery for pelvic organ prolapse in the USA.

Authors:  Aparna D Shah; Neeraj Kohli; Sujatha S Rajan; Lennox Hoyte
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-09-20

8.  Low-weight polypropylene mesh for anterior vaginal wall prolapse: a randomized controlled trial.

Authors:  Reijo Hiltunen; Kari Nieminen; Teuvo Takala; Eila Heiskanen; Mauri Merikari; Kirsti Niemi; Pentti K Heinonen
Journal:  Obstet Gynecol       Date:  2007-08       Impact factor: 7.661

9.  Voiding difficulties after vaginal mesh cystocele repair: does the perivesical dissection matter?

Authors:  Z Rusavy; G Rivaux; B Fatton; M Cayrac; L Boileau; R de Tayrac
Journal:  Int Urogynecol J       Date:  2013-01-11       Impact factor: 2.894

10.  Clinical and urodynamic features of intrinsic sphincter deficiency.

Authors:  Cinzia Pajoncini; Elisabetta Costantini; Federico Guercini; Vittorio Bini; Massimo Porena
Journal:  Neurourol Urodyn       Date:  2003       Impact factor: 2.696

View more
  3 in total

Review 1.  Pelvic Prolapse Repair in the Era of Mesh.

Authors:  Natalie Gaines; Priyanka Gupta; Larry T Sirls
Journal:  Curr Urol Rep       Date:  2016-03       Impact factor: 3.092

2.  Decellularized dermal strip as a suburethral sling in a rat model of stress urinary incontinence.

Authors:  Abdol-Mohammad Kajbafzadeh; Sarah Mozafarpour; Seyedeh Sanam Ladi Seyedian; Reza Khorramirouz; Haleh Nasser Hojjati
Journal:  Int Urol Nephrol       Date:  2015-06-20       Impact factor: 2.370

3.  Additional treatments, satisfaction, symptoms and quality of life in women 1 year after vaginal and abdominal pelvic organ prolapse repair.

Authors:  Laura N Nguyen; Morgan Gruner; Kim A Killinger; Kenneth M Peters; Judith A Boura; Michelle Jankowski; Larry T Sirls
Journal:  Int Urol Nephrol       Date:  2018-03-16       Impact factor: 2.370

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.